Press Releases Year: - Any -20212020201920182017201620152014201320122011 Company News Summary ToggleDavid F. Azad Appointed To Board Of Directors Jul 28, 2011 Read more Summary ToggleAcura Pharmaceuticals Reports 2nd Qtr 2011 Financial Results And Product Development Update Jul 28, 2011 Read more Summary ToggleRobert Jones Appointed President & CEO And To The Board Of Directors Of Acura Pharmaceuticals, Inc. Jul 11, 2011 Read more Summary Toggle Acura Pharmaceuticals, Inc. Announces The Retirement Of William A. Sumner From Board Of Directors Jul 08, 2011 Read more Summary ToggleAcura Pharmaceuticals Receives $20 Million Milestone Payment Jul 01, 2011 Read more Summary Toggle Pfizer And Acura Announce FDA Approval Of Oxecta™ (oxycodone HCl, USP) CII Jun 20, 2011 Read more Summary ToggleAcura Pharmaceuticals, Inc. Announces Notice Of Allowance For Third Aversion® Technology Patent Jun 06, 2011 Read more Summary Toggle Acura Pharmaceuticals, Inc. Announces Appointment Of Robert Jones As Interim President & CEO May 02, 2011 Read more Summary Toggle Acura Pharmaceuticals, Inc. Announces The Passing Of Andrew Reddick, President & CEO Apr 29, 2011 Read more Summary Toggle Acura Pharmaceuticals Reports First Quarter 2011 Financial Results And Product Development Update Apr 28, 2011 Read more Summary Toggle Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave Apr 25, 2011 Read more Summary ToggleAcura Pharmaceuticals Reports Year-End And Fourth Quarter 2010 Financial Results And Product Development Update Mar 01, 2011 Read more Summary ToggleACUROX® Tablets New Drug Application Accepted For Filing With A Priority Review Classification Feb 14, 2011 Read more Pagination First page First Previous page Previous … Page 6 Page 7 Page 8 Current page 9
Facebook
LinkedIn
Twitter